The Digital Apothecary
DECEMBER 24, 2023
So, 2023 is coming to a close, and 2024 is upon us soon. With that being the case, I thought I'd summarize what I have been up to and what I look forward to next year! 2023 Areas of Focus This year, my focus was largely on AI and digital health technologies (DHTs). My anticipation of the societal impact of AI, which I expressed last December, has proven accurate.
Drug Patent Watch
DECEMBER 24, 2023
Annual Drug Patent Expirations for ABILIFY Abilify is a drug marketed by Otsuka and Otsuka Pharm Co Ltd and is included in seven NDAs. It is available from one supplier.… The post New patent expiration for Otsuka drug ABILIFY appeared first on DrugPatentWatch - Make Better Decisions.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
RX Note
DECEMBER 24, 2023
Introduction Learning often cycles between simplicity and complexity. During high school, we learned that cell is the simplest unit of life, yet we may not know how each organelle inside the cell functions. Only in university, we were further introduced with the concept of GPCR pathway, Krebs cycle, action potential in neurons and many mores. Ironically, after learning all these, we are back to simplicity in educating the public when working as a pharmacist.
Drug Patent Watch
DECEMBER 24, 2023
Annual Drug Patent Expirations for ABILIFY+MYCITE+KIT Abilify Mycite Kit is a drug marketed by Otsuka and is included in one NDA. It is available from one supplier. There are twenty-nine… The post New patent expiration for Otsuka drug ABILIFY MYCITE KIT appeared first on DrugPatentWatch - Make Better Decisions.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Med Ed 101
DECEMBER 24, 2023
The (Ambulatory Care Pharmacist) BCACP exam is changing in 2024. Pharmacists should expect a shorter exam. BPS announced that the exam will drop from 175 questions to 150 questions. When the BCACP credential was initially created, the exam was 200 questions. The 2024 BCACP content outline has remained consistent from 2023 so in general I […] The post 2024 BCACP Exam Information appeared first on Med Ed 101.
Pharmaceutical Technology
DECEMBER 24, 2023
Lenvatinib mesylate is under clinical development by Eisai and currently in Phase II for Metastatic Biliary Tract Cancer.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
GMPSOP
DECEMBER 24, 2023
Overview of GLP requirements on everyday laboratory operations Pharmaceuticals quality assurance & validation procedures GMPSOP Overview of GLP requirements on everyday laboratory operations Last Updated on December 24, 2023 Prev PREVIOUS POST Table of Contents Pharmaceutical laboratories conduct sampling, testing, and reporting of medicinal batch results.
Pharmaceutical Technology
DECEMBER 24, 2023
(Curcumin + doxorubicin) is under clinical development by Immix BioPharma and currently in Phase II for Triple-Negative Breast Cancer (TNBC).
Pharmacy Times
DECEMBER 24, 2023
From newsworthy moments to groundbreaking research, these were the most-read student-related articles on Pharmacy Times in 2023.
Pharmaceutical Technology
DECEMBER 24, 2023
(Curcumin + doxorubicin) is under clinical development by Immix BioPharma and currently in Phase II for Metastatic Colorectal Cancer.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Drug Patent Watch
DECEMBER 24, 2023
This chart shows the pharmaceutical companies with the most lotion dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most lotion dosed drugs… The post Which pharmaceutical companies have the most lotion dosed drugs? appeared first on DrugPatentWatch - Make Better Decisions.
Pharmaceutical Technology
DECEMBER 24, 2023
(Curcumin + doxorubicin) is under clinical development by Immix BioPharma and currently in Phase II for Colorectal Cancer.
Pharmaceutical Technology
DECEMBER 24, 2023
Lenvatinib mesylate is under clinical development by Eisai and currently in Phase II for Metastatic Biliary Tract Cancer.
Pharmaceutical Technology
DECEMBER 24, 2023
Mecbotamab vedotin is under clinical development by BioAtla and currently in Phase II for Breast Cancer.
Expert insights. Personalized for you.
130 
Let's personalize your content